
Andrew Gane
Technology Manager, Diagnostics and Genomics, Cytiva
Andrew is responsible for building the innovation pipeline in collaboration with the R&D and commercial teams. His knowledge and understanding of emerging trends and new applications have been fundamental to developing the product portfolio into workflow-based solutions, with a particular focus on next-generation sequencing (NGS). Andrew has more than 30 years of experience in immunodiagnostics and molecular diagnostics in both lab-based and product development roles.

The Future of Diagnostics: Advancements, Challenges and Opportunities
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.

The Future of Diagnostics: Advancements, Challenges and Opportunities
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.